Glucophage Xr is a brand name formulation of the oral antidiabetic medication metformin. It is classified as a biguanide agent used to improve glycemic control in patients with type 2 diabetes mellitus. The drug's primary therapeutic purpose is to lower blood glucose concentrations by reducing hepatic glucose production and enhancing peripheral insulin sensitivity. Metformin acts by inhibiting mitochondrial complex i in liver cells, leading to decreased adenosine triphosphate generation and reduced gluconeogenesis. The inhibition of hepatic gluconeogenesis results in a marked decline in fasting and postprandial glucose levels. In addition, metformin increases the sensitivity of muscle and adipose tissue to insulin, promoting glucose uptake from the bloodstream. Pharmacokinetically the extended-release formulation releases the drug gradually over several hours, maintaining steady plasma concentrations and reducing gastrointestinal side effects. The overall effect of these mechanisms is a sustained improvement in glycemic control without causing hypoglycemia when used as monotherapy.

Glucophage Xr is an extended-release formulation of metformin used to manage type 2 diabetes mellitus. It belongs to the biguanide class and is characterized by slow absorption that maintains stable plasma concentrations over time. The drug lowers blood glucose by decreasing hepatic gluconeogenesis and reducing intestinal glucose absorption. It also enhances peripheral insulin sensitivity which facilitates greater glucose uptake by muscle and adipose tissue. These actions result in a modest reduction of fasting and postprandial glucose levels without stimulating insulin secretion. By improving glycemic control it helps prevent complications associated with uncontrolled diabetes.

Stomach discomfort or nausea can occur when taking Glucophage Xr. Diarrhea or loose stools may appear especially during the initial treatment period. A metallic taste in the mouth has been reported by some users. Occasional abdominal bloating or gas may be experienced. Long-term use may lead to reduced vitamin b12 levels potentially causing fatigue or tingling. In rare cases a serious metabolic condition called lactic acidosis may develop. Headaches and mild dizziness are also possible side effects.

Glucophage Xr may cause gastrointestinal discomfort such as nausea or diarrhea. It can sometimes lead to a metallic taste in the mouth. Low blood sugar levels, known as hypoglycemia, are possible if the dose is too high or if it is combined with other glucose-lowering medications. Some users report skin rash or itching as a dermatological reaction. Rarely, the medication may affect kidney function, especially in individuals with pre-existing renal impairment. It can cause dizziness or light-headedness, particularly when standing up quickly. Swelling of the hands or feet, known as peripheral edema, has been reported in some cases. Long-term use may rarely lead to a vitamin b12 deficiency, which can cause fatigue and nerve symptoms.